This new trial built on a previous one published in NEJM last fall (I previously reviewed here) for the same indication, but the only difference was the inclusion of people with diabetes
call 999 or attend A&E immediately if serious symptoms develop
GLP-1s can make the body smaller, but that doesnt mean its safer to conceive
Most people report that by week six to eight, the side effects have diminished significantly while the appetite suppression and metabolic benefits continue building
Why aren't there more?" ama-assn.org Last updated: January 5, 2026 Fact-checked with deep research Reviewed monthly as pricing and availability change Disclaimer The information on this page is for educational and informational purposes only and is not intended as medical advice
Tirzepatide, also known as Zepbound when prescribed for weight loss, is a dual agonist, targeting GLP-1 and GIP receptors